part Part I: Immunotoxicology and Hazard Identification -- chapter 1 Immunotoxicology: Thirty Years and Counting / chapter 2 Immunotoxicity Hazard Identifi cation and Testing Guidelines / chapter 3 Interpreting Immunotoxicology Data for Risk Assessment / chapter 4 Mechanisms of Immunotoxicity / chapter 5 Animal and In Vitro Models of Immunotoxicity / chapter 6 The Promise of Genomics and Proteomics in Immunotoxicology and Immunopharmacology / chapter 7 The Use of Multiparameter Flow Cytometry in Immunotoxicology and Immunopharmacology / part Part II: Immunopharmacology and Immunotoxicology of Therapeutics -- chapter 8 Targeted Therapeutic Immune Response Modulators / chapter 9 Immunoaugmenting Therapeutics: Recombinant Cytokines and Biological Response Modifi ers / chapter 10 Opioid-Induced Immunomodulation / chapter 11 Immunomodulation by Nutraceuticals and Functional Foods / part Part III: Environmental Agents -- chapter 12 Lead Immunotoxicity / chapter 13 Immunotoxicology of Jet Propulsion Fuel-8 / chapter 14 Immune Modulation by TCDD and Related Polyhalogenated Aromatic Hydrocarbons / chapter 15 Mechanisms by Which Ultraviolet Radiation, a Ubiquitous Environmental Toxin, Suppresses the Immune Response / chapter 16 Immunotoxicology and Infl ammatory Mechanisms of Arsenic / chapter 17 Modulation of Infl ammatory Gene Expression by Trichothecene Mycotoxins / part Part IV: Immunotoxicity in the Lung -- chapter 18 Host Defense and Immunotoxicology of the Lung / part Part V: Developing Immunotoxicity -- chapter 19 Immune System Ontogeny and Developmental Immunotoxicology / chapter 20 Development of a Framework for Developmental Immunotoxicity (DIT) Testing / part Part VI: Wildlife Immunotoxicology -- chapter 21 Invertebrate Immunotoxicology / chapter 22 Amphibian, Fish, and Bird Immunotoxicology / chapter 23 Marine Mammal Immunotoxicology / part Part VII: Autoimmunity and Autoimmune Diseases -- chapter 24 Immunopathogenesis of Autoimmune Diseases / chapter 25 Environmental Infl uences on Autoimmunity and Autoimmune Diseases / chapter 26 Drug-Induced Autoimmune Disease / chapter 27 Experimental Models of Autoimmunity / part Part VIII: Neuroimmunology -- chapter 28 An Overview of Neural-Immune Communication in Development, Adulthood, and Aging / chapter 29 Stress, Immune Function, and Resistance to Disease: Human and Rodent Models / chapter 30 Recreational Drugs, Immune Function, and Resistance to Infection / part Part IX: Allergy and Hypersensitivity -- chapter 31 Allergy to Chemicals and Proteins: An Introduction / chapter 32 Allergic Contact Dermatitis to Chemicals: Immunological and Clinical Aspects / chapter 33 Respiratory Allergy and Occupational Asthma -- chapter 34 Chemical Allergy: Hazard Identifi cation, Hazard Characterization, and Risk Assessment / chapter 35 Food Allergy: Immunological Aspects and Approaches to Safety Assessment / chapter 36 Drug Allergy